Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Angiogenesis Inhibitors
Animals
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal
Apoptosis
Apoptosis
Brain Neoplasms
Brain Neoplasms
Cell Proliferation
Cell Proliferation
Disease Models, Animal
Disease Models, Animal
Glioma
Glioma
Humans
Humans
Male
Male
Mice
Mice
Mice, Inbred C57BL
Mice, Inbred C57BL
Mice, Nude
Mice, Nude
Neovascularization, Pathologic
Neovascularization, Pathologic
Receptors, G-Protein-Coupled
Receptors, G-Protein-Coupled
Tumor Cells, Cultured
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
James Battiste
Kar-Ming Fung
Megan Ross Lerner
Jonathan D. Wren